| Financial Year |
March 31 2023 |
| Monetary Funds |
1,045,759,972.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,764,412.71 |
| Accounts Receivable |
288,656,295.32 |
| Advances to Suppliers |
23,401,745.81 |
| Other Receivables |
9,363,926.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
372,887,317.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,221,978.08 |
| Total Current Assets |
1,798,683,546.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
516,211.50 |
| Fixed Assetes |
314,898,773.12 |
| Under-construction Projects |
202,134,852.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
174,666,183.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
14,206,914.90 |
| Other Non-Current Assets |
25,481,715.84 |
| Sub-Total of Non-Current Assets |
736,904,652.15 |
| Total Assets |
2,535,588,198.31 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
53,326,758.58 |
| Accounts Payable |
286,031,380.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,788,200.85 |
| Taxes Payable |
11,395,570.13 |
| Interest Payable |
572,054.79 |
| Dividend Payable |
-- |
| Other payables |
12,280,066.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
5,712,686.07 |
| Sub-Total of Current Liabilities |
508,113,665.62 |
| Long-term Loans |
-- |
| Bonds Payable |
380,671,077.89 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,231,912.06 |
| Deferred Income Tax Liabilities |
9,557,427.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
414,555,166.37 |
| Total Liabilities |
922,668,831.99 |
| Paid-In Capital(Or Share Stock) |
166,777,200.00 |
| Capital Surplus |
462,780,659.46 |
| Surplus Reserve |
93,043,019.14 |
| LESS:Treasury Stock |
10,225,857.00 |
| Undistributed Profits |
830,713,783.13 |
| Minority Stockholder's Interest |
9,478,274.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,603,441,091.82 |
| Owner's Equity（Stockholder's Equity） |
1,612,919,366.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,535,588,198.31 |
